Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
FEXOFENADINE HYDROCHLORIDE
Profind Wholesale Ltd.
120 Milligram
Film Coated Tablet
2011-03-21
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Telfast 120mg film-coated tablets. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 120 mg of fexofenadine hydrochloride, which is equivalent to 112 mg of fexofenadine. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film coated tablets. _Product imported from Hungary:_ Peach, capsule-shaped tablet debossed with '012' on one side and 'e' on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Relief of symptoms associated with seasonal allergic rhinitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _ADULTS AND CHILDREN AGED 12 YEARS AND OVER_ The recommended dose of fexofenadine hydrochloride for adults and children aged 12 years and over is 120 mg once daily taken before a meal. Fexofenadine is a pharmacologically active metabolite of terfenadine. _CHILDREN UNDER 12 YEARS OF AGE_ The efficacy and safety of fexofenadine hydrochloride has not been studied in children under 12. _SPECIAL RISK GROUPS_ Studies in special risk groups (elderly, renally or hepatically impaired patients) indicate that it is not necessary to adjust the dose of fexofenadine hydrochloride in these patients. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE As with most new drugs there is only limited data in the elderly and renally or hepatically impaired patients. Fexofenadine hydrochloride should be administered with care in these special groups. Patients with a history of or ongoing cardiovascular disease should be warned that, antihistamines as a drug class, have been associated with the adverse events, tachycardia and palpitations _(see section 4.8)._ IRISH MEDICINES BOARD _______________________________________ Lue koko asiakirja